Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Finel

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Biochimica Et Biophysica Acta|May 17, 2005
Functional studies with membrane-bound and detergent-solubilized alpha2-adrenergic receptors expressed in Sf9 cellsSaurabh Sen, Veli-Pekka Jaakola, Päivi Pirilä, et al.
Molecular Pharmaceutics|December 15, 2016
UGT1A10 Is a High Activity and Important Extrahepatic Enzyme: Why Has Its Role in Intestinal Glucuronidation Been Frequently Underestimated?Johanna Troberg, Erkka Järvinen, Guang-Bo Ge, et al.
Biological Chemistry|April 12, 2006
Chiral distinction between the enantiomers of bicyclic alcohols by UDP-glucuronosyltransferases 2B7 and 2B17Ingo Bichlmaier, Antti Siiskonen, Mika Kurkela, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 9, 2007
Evaluation of synthetic polymeric micelles as a stabilization medium for the handling of membrane proteins in pharmaceutical drug discoveryOlga V Trubetskoy, Moshe Finel, Thomas J Burke, et al.
Bioorganic Chemistry|August 21, 2007
Eudismic analysis of tricyclic sesquiterpenoid alcohols: lead structures for the design of potent inhibitors of the human UDP-glucuronosyltransferase 2B7Ingo Bichlmaier, Mika Kurkela, Antti Siiskonen, et al.
Basic & Clinical Pharmacology & Toxicology|June 26, 2019
Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transportersErkka Järvinen, Noora Sjöstedt, Jan B Koenderink, et al.
Steroids|August 18, 2011
Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogensCamilla Höglund, Nina Sneitz, Anna Radominska-Pandya, et al.
Journal of Chemical Information and Modeling|March 5, 2014
SVM classification and CoMSIA modeling of UGT1A6 interacting moleculesLeo Ghemtio, Anne Soikkeli, Marjo Yliperttula, et al.
Molecular Pharmacology|June 5, 2008
Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene inductionMichael H Court, Suwagmani Hazarika, Soundararajan Krishnaswamy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2009
Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10Oranun Kerdpin, Peter I Mackenzie, Kushari Bowalgaha, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Biochimica Et Biophysica Acta|May 17, 2005
Functional studies with membrane-bound and detergent-solubilized alpha2-adrenergic receptors expressed in Sf9 cellsSaurabh Sen, Veli-Pekka Jaakola, Päivi Pirilä, et al.
Molecular Pharmaceutics|December 15, 2016
UGT1A10 Is a High Activity and Important Extrahepatic Enzyme: Why Has Its Role in Intestinal Glucuronidation Been Frequently Underestimated?Johanna Troberg, Erkka Järvinen, Guang-Bo Ge, et al.
Biological Chemistry|April 12, 2006
Chiral distinction between the enantiomers of bicyclic alcohols by UDP-glucuronosyltransferases 2B7 and 2B17Ingo Bichlmaier, Antti Siiskonen, Mika Kurkela, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 9, 2007
Evaluation of synthetic polymeric micelles as a stabilization medium for the handling of membrane proteins in pharmaceutical drug discoveryOlga V Trubetskoy, Moshe Finel, Thomas J Burke, et al.
Bioorganic Chemistry|August 21, 2007
Eudismic analysis of tricyclic sesquiterpenoid alcohols: lead structures for the design of potent inhibitors of the human UDP-glucuronosyltransferase 2B7Ingo Bichlmaier, Mika Kurkela, Antti Siiskonen, et al.
Basic & Clinical Pharmacology & Toxicology|June 26, 2019
Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transportersErkka Järvinen, Noora Sjöstedt, Jan B Koenderink, et al.
Steroids|August 18, 2011
Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogensCamilla Höglund, Nina Sneitz, Anna Radominska-Pandya, et al.
Journal of Chemical Information and Modeling|March 5, 2014
SVM classification and CoMSIA modeling of UGT1A6 interacting moleculesLeo Ghemtio, Anne Soikkeli, Marjo Yliperttula, et al.
Molecular Pharmacology|June 5, 2008
Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene inductionMichael H Court, Suwagmani Hazarika, Soundararajan Krishnaswamy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2009
Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10Oranun Kerdpin, Peter I Mackenzie, Kushari Bowalgaha, et al.
Pageof 13